A Phase 2, Multicenter, Double-blind and Placebo and Active Control Study to Evaluate the Initial Efficacy and Safety of X0002 Spray in Treatment of Subjects With Osteoarthritis of the Knee
Phase of Trial: Phase II
Latest Information Update: 24 Jan 2019
Price : $35 *
At a glance
- Drugs Ibuprofen (Primary) ; Ibuprofen (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Tianjin XinChen-Techfields Pharma
- 15 Jan 2019 Status changed from not yet recruiting to recruiting.
- 10 Oct 2018 New trial record
- 09 Oct 2018 Planned initiation date changed from 28 Sep 2018 to 10 Oct 2018.